Gomesin, a peptide produced by the spiderAcanthoscurria gomesiana, is a potent anticryptococcal agent that acts in synergism with fluconazole
Open Access
- 1 September 2007
- journal article
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 274 (2) , 279-286
- https://doi.org/10.1111/j.1574-6968.2007.00850.x
Abstract
Gomesin is an 18-residue cysteine-rich antimicrobial peptide produced by hemocytes of the spider Acanthoscurria gomesiana. In the present study, theKeywords
This publication has 22 references indexed in Scilit:
- Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp.Experimental Parasitology, 2007
- Biological and structural characterization of new linear gomesin analogues with improved therapeutic indicesPeptide Science, 2006
- Cationic amphipathic histidine-rich peptides for gene deliveryBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damageMicrobes and Infection, 2006
- Structure–activity relationship studies of gomesin: Importance of the disulfide bridges for conformation, bioactivities, and serum stabilityPeptide Science, 2005
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005
- Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coliBiochemical Journal, 2004
- Cryptococcus neoformans CAP59 (or Cap59p) Is Involved in the Extracellular Trafficking of Capsular GlucuronoxylomannanEukaryotic Cell, 2004
- Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism.The Journal of Experimental Medicine, 1994
- Monoclonal antibody based ELISAs for cryptococcal polysaccharideJournal of Immunological Methods, 1992